Jonathan Wall, PhD, a professor at the University of Tennessee Health Science Center’s Graduate School of Medicine (GSM) in Knoxville, has been appointed as a University Distinguished Professor. The title is reserved for those who have contributed in a superlative way to UTHSC and brought distinction and respect to the university. Dr. Wall’s appointment comes… Read More
The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled “Developing a Theranostic Immunotherapy for Systemic Amyloidosis.” Amyloidosis is a rare disease that occurs when abnormal protein… Read More
Improved poultry feeders, treatments for ophthalmic and renal diseases, human and veterinary diagnostic tests, and a novel treatment for canine infections are among the recipients of this year’s maturation funding from the University of Tennessee Research Foundation (UTRF). Four teams affiliated with the University of Tennessee Health Science Center (UTHSC) received funding. They are: •… Read More
The amyloidoses are a group of rare diseases that are a consequence of abnormal protein (amyloid) deposits in various body tissues and organs. Characterized as systemic or localized, light chain-associated amyloidosis (AL) is the most common form of systemic amyloid disease, with an estimated 4,500 new cases each year in the United States. Systemic amyloid… Read More
